Experimental in vitro phenotype reprogramming of two subsets of neutrophilic granulocytes in children with acute destructive pneumonia by means of a synthetic hexapeptide

Cover Page

Cite item

Full Text

Abstract

Effector dysfunctions of neutrophil granulocytes are often associated with the occurrence of dysregulatory processes in the antibacterial immune defense. Acute destructive pneumonia is a severe purulent-inflammatory disease associated with discordant functions of effector mechanisms of neutrophil granulocytes and emergence of negatively transformed cell subsets. Therefore, the search for new experimental approaches aimed at re-orientation of negatively altered phenotype of distinct subsets of neutrophilic granulocytes in the children with acute destructive pneumonia by means of various immunotropic substances is quite relevant. The aim of the study was to evaluate the modulating effects of synthetic hexapeptide (Arginyl-alpha-Aspartyl-Lysyl-Valyl-Tyrosyl-Arginine) on the contents and phenotype of 2 functionally significant subsets of major (CD16+CD64-CD32+CD11b+) and minor (CD16+CD64+CD32+CD11b+) subpopulations of neutrophils in a «closed in vitro experimental system» sampled in the children with atypical acute destructive pneumonia. We have examined twenty peripheral blood samples from 10 children with acute destructive pneumonia, and 40 blood samples of 20 healthy children 2-4 years old. Immunophenotyping of neutrophil granulocytes classified in 2 subsets was performed on the basis of expression density of membrane receptors, according to MFI criteria. Phenotypic features of neutrophil granulocyte subsets were evaluated in the in vitro system before and after incubation of peripheral blood with Hexapeptide (10-6 g/L; 37 °C, 60 min). In children with acute destructive pneumonia, compared with conditionally healthy children, the following variants of negative transformation of the neutrophil subsets were established: a significant decrease in the ratios of the major subset, i.e., from 98.0 (96.9-98.7) % o 55.8 (35.3-74.8) %, with a decreased CD16 and CD11b density expression according to MFI, and a significantly increase ratio of the minor neutrophil subset: from 1.3 (0.4-1.6) % to 52.6 (41.8-54.9) %, with increased expression of CD11b receptor, and a decrease in CD64 expression. Immunomodulatory effects of Hexapeptide upon neutrophil granulocytes of children with acute destructive pneumonia have been demonstrated in the closed in vitro system showing positive phenotype remodeling of both cell subsets in the absence of significant quantitative changes. Thus, upon treatment with the hexapeptide, we have found a significantly increased expression of activation receptors CD16, CD11b in the major subset, and a significant decrease in their expression for the minor subset to the levels typical to healthy children. At the same time, hexapeptide did not affect the studied subsets of neutrophils from healthy children, except of increased CD64 expression in the minor subset. The obtained data can be used in future to develop new approaches to the targeted immunotherapy aimed at correcting the phenotype of neutrophil granulocyte subsets in acute destructive pneumonia in children.

About the authors

I. V. Nesterova

Kuban State Medical University; Peoples’ Friendship University of Russia

Author for correspondence.
Email: inesterova1@yandex.ru

MD, PhD (Medicine), Professor, Chief Research Associate, Department of Clinical and Experimental Immunology and Molecular Biology, Central Research Laboratory; Professor, Department of Allergology and Immunology, Faculty of Continuing Medical Education

Russian Federation, Krasnodar; Moscow

V. N. Chapurina

Kuban State Medical University

Email: inesterova1@yandex.ru

Assistant Professor, Department of Clinical Immunology, Allergology and Laboratory Diagnostics

Russian Federation, Krasnodar

G. A. Chudilova

Kuban State Medical University

Email: inesterova1@yandex.ru

PhD, MD (Biology), Associate Professor, Head, Department of Clinical and Experimental Immunology and Molecular Biology, Central Research Laboratory; Professor, Department of Clinical Immunology, Allergology and Laboratory Diagnostics

Russian Federation, Krasnodar

V. A. Tarakanov

Kuban State Medical University

Email: inesterova1@yandex.ru

MD, PhD (Medicine), Professor, Head, Department of Surgical Diseases in Childhood

Russian Federation, Krasnodar

References

  1. Долгушин И.И. Нейтрофильные гранулоциты: новые лица старых знакомых // Бюллетень сибирской медицины, 2019. Т. 18, № 1. С. 30-37. [Dolgushin I.I. Neutrophil granulocytes: new faces of old acquaintances. Byulleten sibirskoy meditsiny = Bulletin of Siberian Medicine, 2019, Vol. 18, no. 1, pp. 30-37. (In Russ.)]
  2. Маркова Т.П., Чувиров Д.Г. Имунофан в комплексном лечении детей c повторными респираторными заболеваниями и микоплазменной инфекцией // Эффективная фармакотерапия, 2022. Т. 18, № 12. С. 12-18. [Markova T.P., Chuvirov D.G. Immunotherapy with imunofan to the treatment of children with recurrent respiratory deseasis and mycoplasma pneumoniae infection. Effektivnaya farmakoterapiya = Effective Pharmacotherapy, 2022, Vol. 18, no. 12, pp. 12-18. (In Russ.)]
  3. Мехриддинов М.К. Роль иммунологических факторов в патогенезе развития деструктивных форм пневмоний у детей // Central Asian Journal of Medical and Natural Sciences, 2022. Т. 3, №. 2. С. 234-238. [Mehriddinov M.K. The role of immunological factors in the pathogenesis of the development of destructive forms of pneumonia in children. Central Asian Journal of Medical and Natural Sciences, 2022, Vol. 3, no. 2, pp. 234-238.
  4. Нестерова И.В., Ковалева С.В., Чудилова Г.А., Малиновская В.В. Интерфероно- и иммунотерапия в реабилитации иммунокомпрометированных детей с возвратными респираторными инфекциями // Иммунотерапия в практике ЛОР-врача и терапевта / Под ред. А.С. Симбирцев, Г.В. Лавренова. СПб.: Диалог, 2018. С. 167-189. [Nesterova I.V., Kovaleva S.V., Chudilova G.A., Malinovskaya V.V. Interferon and immunotherapy in the rehabilitation of immunocompromised children with recurrent respiratory infections. Immunotherapy in the practice of ENT doctor and therapist / Ed. Simbirtsev A.S., Lavrenova G.V.] St. Petersburg: Dialog, 2018, pp. 167-189.
  5. Нестерова И.В., Колесникова Н.В., Чудилова Г.А., Ломтатидзе Л.В., Ковалева С.В., Евглевский А.А., Нгуен Т.Л. Новый взгляд на нейтрофильные гранулоциты: переосмысление старых догм. Часть 2 // Инфекция и иммунитет, 2018. Т. 8, № 1. С. 7-18. [Nesterova I.V., Kolesnikova N.V., Chudilova G.A., Lomtatidze L.V., Kovaleva S.V., Evglevsky A.A., Nguyen T.L. The new look at neutrophilic granulocytes: rethinking old dogmas. Part 2. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2018, Vol. 8, no. 1. pp. 7-18. (In Russ.)] doi: 10.15789/2220-7619-2018-1-7-18.
  6. Оптимизация диагностики и лечения гнойно-воспалительных заболеваний (Инновационные технологии): Практическое руководство / Под ред. Ревишвили А.Ш., Земскова В.М., Земскова А.М. СПб.: СпецЛит, 2020. 319 с. [Optimization of diagnostics and treatment of purulent-inflammatory diseases (innovative technologies) / Ed. Revishvili A.Sh., Zemskov V.M., Zemskov A.M.]. St. Petersburg: SpetsLit, 2020. 319 p.
  7. Hong C.W. Current understanding in neutrophil differentiation and heterogeneity. Immune Netw., 2017, Vol. 17, no. 5, pp. 298-306.
  8. Neutrophils. Ed. Khajah M. London: Intechopen limited, 2019. 85 p.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Nesterova I.V., Chapurina V.N., Chudilova G.A., Tarakanov V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies